Dengue Vaccine Market Predicted To Garner USD 1,755.8 Million By 2033, At CAGR 13.2% | Exclusive Report By Marketresearch.Biz
Marketresearch.biz reports that the Dengue Vaccine Market was valued at USD 524.2 million in 2023, It is expected to reach USD 1,755.8 million by 2033, with a CAGR of 13.2% during the forecast period from 2024 to 2033. Overview for Dengue Vaccine Market Dengue, a mosquito-borne viral infection, poses a significant global health threat. The Dengue Vaccine Market is witnessing robust growth due to increasing awareness and the pressing need for preventive measures. With advancements in vaccine development, this market segment holds promising potential in combating Dengue outbreaks. Driving Factors of the Dengue Vaccine Market Increasing Dengue Prevalence: Rising incidences…
- Date: March 12, 2024
- Author: Rohan Gadekar
- Category: PharmiWeb